山茶提取物对人角膜上皮细胞的抗炎抗氧化作用及实验性干眼疗效的体内外研究
研究评估山茶(CJ)提取物对人角膜上皮(HCE)细胞及小鼠实验性干眼(EDE)模型的抗炎抗氧化作用。体外0.01%和0.1% CJ减少HCE细胞凋亡并改善PRX1、4、5及MnSOD表达;体内0.1% CJ显著改善临床参数,0.01%和0.1% CJ降低炎症标志物和细胞内ROS。作者认为含CJ提取物的滴眼液可作为干眼的辅助治疗。
要点
- 0.01%和0.1%山茶提取物减少HCE细胞凋亡并改善PRX1、4、5与MnSOD蛋白表达。
- 0.1%山茶提取物滴眼显著改善小鼠EDE临床参数,优于EDE对照和BSS组。
- 0.01%和0.1%山茶提取物组炎症标志物和细胞内ROS水平显著降低。
核心结论
- 山茶提取物促进HCE细胞抗氧化蛋白表达并抑制凋亡。
- 山茶提取物改善干眼临床体征并降低氧化应激和炎症标志物表达,提示含山茶提取物滴眼液可作为干眼辅助治疗。
研究设计与样本
- 体外研究:用0.001%、0.01%、0.1%山茶提取物处理HCE细胞,行DCF-DA和DHE检测,Western blot分析PRX1-6和MnSOD。
- 体内研究:小鼠实验性干眼(EDE)模型,分别给予含0.001%、0.01%、0.1%山茶提取物或平衡盐溶液(BSS)的滴眼液,治疗7天后测量临床参数、炎症标志物和细胞内ROS。
主要发现
- 0.01%和0.1%山茶提取物处理减少HCE细胞凋亡。
- H2O2处理后,0.01%和0.1%山茶提取物预处理组PRX1、4、5及MnSOD条带强度显著改善。
- 0.1%山茶提取物组小鼠临床参数显著优于EDE对照组和BSS组。
- 0.01%和0.1%山茶提取物组炎症标志物水平和细胞内ROS显著降低。
临床怎么用
- 作者认为含山茶提取物的滴眼液可作为干眼的辅助治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the anti-inflammatory and antioxidative effects of Camellia japonica (CJ) on human corneal epithelial (HCE) cells and its therapeutic effects in a mouse model of experimental dry eye (EDE). METHODS: Camellia japonica extracts of varying concentrations (0.001%, 0.01%, and 0.1%) were used to treat HCE cells. Dichlorofluorescein diacetate (DCF-DA) and dihydroethidium (DHE) assays were performed. The production of peroxiredoxin (PRX) 1-6 and manganese-dependent superoxide dismutase (MnSOD) in HCE cells was assessed using Western blot analysis. Furthermore, eye drops containing 0.001%, 0.01%, or 0.1% CJ extract or a balanced salt solution (BSS) were applied to the EDE. Clinical parameters were measured 7 days after treatment. The levels of inflammatory markers and intracellular reactive oxygen species (ROS) were measured. RESULTS: Treatment with 0.01% and 0.1% CJ extracts decreased apoptosis in HCE cells. In addition, band intensities of PRX 1, 4, and 5, as well as MnSOD, after hydrogen peroxide (H2O2) treatment showed a significant improvement after pretreatment with 0.01% and 0.1% CJ extracts. Mice treated with 0.1% CJ extract showed significantly improved clinical parameters when compared to those of the EDE control and BSS groups. A significant decrease in the levels of inflammatory markers and intracellular ROS was observed in the 0.01% and 0.1% CJ extract groups. CONCLUSIONS: Camellia japonica extracts promoted antioxidative protein expression and suppressed apoptosis in HCE cells. Furthermore, CJ extracts improved clinical signs of dry eye and reduced oxidative stress and the expression of inflammatory markers, suggesting that eye drops containing CJ extract could be used as an adjunctive treatment for dry eye.
引用
- Lee HS, Choi JH, Cui L, et al. Anti-Inflammatory and Antioxidative Effects of Camellia japonica on Human Corneal Epithelial Cells and Experimental Dry Eye: In Vivo and In Vitro Study. Invest Ophthalmol Vis Sci. 2017. PMID: 28245300. doi:10.1167/iovs.16-20634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。